
Coronavirus vaccine candidate from Oxford University and AstraZeneca shows robust humoral and cellular response; phase 2/3 trials underway.

Coronavirus vaccine candidate from Oxford University and AstraZeneca shows robust humoral and cellular response; phase 2/3 trials underway.

Hand sanitizer products contaminated with methyl alcohol have caused serious adverse events, including hospitalization, blindness, and death.

Medicare beneficiary use of telehealth services reached nearly 9 million as COVID-19 shut down on-site visits. Will the options be permanent?

VIDEO: Obesity is a chronic, relapsing disease that threatens to neutralize, even reverse, years of progress in reducing CVD-related death. Ted Kyle, RPh, explores.

Parental doubts about efficacy drive flu-shot hesitancy, according to a new survey, and impact routine vaccination rates, as well.

Cardiothoracic surgeon Brian Lima, MD spent weeks in a large metropolitan New York City ICU treating the sickest patients with COVID-19. He shares details.

Effective ways to limit SARS-CoV2 spread are reasonably well understood, say US adults, and the science can be trusted, even though advice keeps changing.

The EUA is the third for diagnostics designed for detection and differentiation of the viruses that cause COVID-19 and the flu.

Jorge Plutzky, MD, director of the Preventive Cardiology Program at Brigham and Women's Hospital, discusses the insidious role diabetes plays in cardiovascular disease.

Blood type and susceptibility to COVID-19 and severe infection are being linked in an increasing number of studies, including a recent genomewide association study published in NEJM.

A letter to the World Health Organization signed by more than 200 scientists from around the world strongly urges the agency to acknowledge airborne transmission of the SARS-Cov2 virus.

Data on physician malpractice rates are broken down across type of practice ownership, gender, age, geographic region, community type, and more.

Home blood pressure monitoring, performed accurately, is the key to data that will guide optimal hypertension treatment. Dr Naomi Fisher talks with Patient Care.

Ketamine used in patients with treatment-resistant depression operates via serotonin 1B receptors by way of a previously unknown mechanism of action, according to a new study from Sweden.

Why are people with obesity at high risk for severe COVID-19 infection? Dr Caroline Apovian explains that immunity in this population has begun to senesce.

The NIH COVID-19 Treatment Guidelines Panel published guidelines on use of the corticosteroid dexamethasone in patients severely ill with COVID-19.

Metabolic and bariatric surgery are deemed "elective," along with cosmetic procedures, and still widely postponed. "Resume these life-saving procedures, now," says the ASMBS.

COVID-19 patients admitted to ICU found 10 times more likely than other hospitalized COVID-19 patients to experience cardiac arrhythmias in a new study.

Roux-en-Y gastric bypass remains the gold standard of bariatric surgery. Obesity and nutrition expert Caroline Apovian, MD, explains why and how it differs from the 3 other types of weight loss surgery.

Which of your patients will use telemedicine now? What type of care will they seek via telehealth? How many would much rather see you in person? More insights from a new survey.

Incident cardiovascular disease is significantly increased among women with migraine with aura vs migraineurs without aura and those who do not have migraine.

Prolonged "air hunger" induced during mechanical ventilation for severe COVID-19 infection can be eliminated by a change in standard of care, a new paper suggests.

VIDEO: Kieran Docherty, MBChB, discusses results of the DAPA-HF analysis on the impact of background T2D therapy on clinical outcomes in patients with T2D and HFrEF.

It’s a good idea to wear a mask while exercising and to thoroughly clean shoes to avoid bringing COVID-19 into the home, correct? Here are a few new myths your patients may be sharing.

Analysis of data from more than 21 000 migraineurs found that less than 1 in 3 take prescribed acute medications and less than 1 in 5 take prescribed preventive agents.

ADA 2020. Average A1c for a recent young cohort with type 2 diabetes was 8.5%, according to research presented at the ADA Virtual Scientific Sessions.

New data from the Diabetes Prevention Outcomes Study shows persistent reduction of type 2 diabetes development over 22-year average follow-up.

VIDEO: Silvio Inzucchi, MD, discusses results of a prespecified analysis of the DAPA-HF trial, which found that dapagliflozin reduced new onset diabetes by 32% in patients with heart failure.

ADA 2020: Glycemic control was worse for black patients who experienced hurried interaction with healthcare providers than for those who did not, a new study reports.

ADA 2020. Improvement in glycemic control among US veterans was seen across 5 study sites and was sustained at 18 months after study initiation, says study reported at the ADA 80th Virtual Scientific Sessions.